Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-08-30
Summary
This study is to evaluate brain and kidney injuries in full-term neonates with perinatal asphyxia by detecting specific biomarker in blood (Erythropoietin).
Conditions
- Perinatal Hypoxia
Interventions
- DIAGNOSTIC_TEST
-
Serum erythropoietin level
Evaluate serum erythropoietin level in neonates exposed to hypoxia compared to control group
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Yosra Aboelnaga · [email protected]
-
Nermine Riad · [email protected]
Eligibility
- Min Age
- 1 Day
- Max Age
- 4 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-06-15
Countries
- Egypt
Study Locations
More Related Trials
-
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
NCT00491413 ·Status: UNKNOWN ·Phase: PHASE1
-
Reno-protective Effect of Brain Cooling in Newborn With Hypoxia
NCT02683915 ·Status: COMPLETED
-
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
NCT02002039 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)
NCT02349672 ·Status: COMPLETED
-
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263 ·Status: COMPLETED ·Phase: PHASE3
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073 ·Status: COMPLETED ·Phase: PHASE4
-
Neonatal Hypoxic Ischemic Encephalopathy:Early Diagnosis and Management of Comorbidities
NCT03550612 ·Status: UNKNOWN
-
Severity of Hypoxic Ischemic Encephalopathy and Neurological Pupil Index in Neonates
NCT07024771 ·Status: NOT_YET_RECRUITING
-
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
NCT01207778 ·Status: COMPLETED
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
NCT05986994 ·Status: UNKNOWN
-
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
NCT00808704 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
NCT01913340 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Optimized Erythropoietin (EPO) Treatment
NCT02075970 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin for Neuroprotection Following Perinatal Asphyxia
NCT02071160 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Thyroid Function in Sick and Healthy Preterm Infants Admitted in NICU of Assiut University Children Hospital
NCT05632965 ·Status: UNKNOWN
-
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Measurement of Cerebral and Peripheric Tissue Oxygenation in Anemic Preterm Infants Who Underwent Blood Transfusion
NCT01251068 ·Status: UNKNOWN ·Phase: NA
-
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
NCT05581927 ·Status: WITHDRAWN ·Phase: NA
-
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
NCT03835039 ·Status: TERMINATED
-
Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants
NCT05372211 ·Status: UNKNOWN
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3